Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia. [electronic resource]
Producer: 20200225ISSN:- 1098-6596
- Adult
- Anti-Bacterial Agents -- therapeutic use
- Australia
- Bacterial Proteins -- genetics
- Cystic Fibrosis -- drug therapy
- Drug Resistance, Microbial -- drug effects
- Humans
- Mutation -- genetics
- Phylogeny
- Pseudomonas Infections -- drug therapy
- Pseudomonas aeruginosa -- drug effects
- Rifampin -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.